Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × sargramostim × Clear all

Sponsor

Conditions

Leukemia 16 Lymphoma 10 Leukemia, Myeloid, Acute 9 Breast Neoplasms 9 Neuroblastoma 8 Myelodysplastic Syndromes 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Ovarian Neoplasms 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Multiple Myeloma 6 Melanoma 6 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Ganglioneuroblastoma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Hodgkin Disease 2 Gliosarcoma 2

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡